Stock Scorecard



Stock Summary for Exagen Inc (XGN) - $1.54 as of 3/27/2024 10:50:45 AM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for XGN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for XGN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for XGN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for XGN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for XGN

Exagen Inc. ( XGN ) Reports Q4 Loss, Tops Revenue Estimates 3/18/2024 1:25:00 PM
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results 3/18/2024 12:00:00 PM
Cresco Labs Inc. ( CRLBF ) Q4 Earnings and Revenues Surpass Estimates 3/16/2024 12:25:00 AM
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Exagen ( NASDAQ:XGN ) 3/8/2024 2:00:00 PM
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum 3/8/2024 2:00:00 PM
Zynex Inc. ( ZYXI ) Q4 Earnings and Revenues Miss Estimates 2/29/2024 10:20:00 PM
Despite Fast-paced Momentum, Exagen Inc. ( XGN ) Is Still a Bargain Stock 2/6/2024 1:50:00 PM
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance 1/7/2024 5:00:00 PM
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting 9/28/2023 8:05:00 PM
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Exagen ( NASDAQ:XGN ) 9/12/2023 8:05:00 PM

Financial Details for XGN

Company Overview

Ticker XGN
Company Name Exagen Inc
Country USA
Description Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The company is headquartered in Vista, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2023
Next Earnings Date 5/13/2024

Stock Price History

Last Day Price 1.54
Last Day Price Updated 3/27/2024 10:50:45 AM EST
Last Day Volume 48,233
Average Daily Volume 44,301
52-Week High 3.92
52-Week Low 1.33
Last Price to 52 Week Low 15.79%

Valuation Measures

Trailing PE N/A
Industry PE 261.00
Sector PE 60.76
5-Year Average PE -4.99
Free Cash Flow Ratio 0.73
Industry Free Cash Flow Ratio 16.58
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 4.02
Total Cash Per Share 2.12
Book Value Per Share Most Recent Quarter 1.33
Price to Book Ratio 1.08
Industry Price to Book Ratio 2.70
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.49
Industry Price to Sales Ratio Twelve Trailing Months 1.49
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 17,235,800
Market Capitalization 26,543,132
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 50.01%
Reported EPS 12 Trailing Months -1.34
Reported EPS Past Year -1.34
Reported EPS Prior Year -2.68
Net Income Twelve Trailing Months -23,689,000
Net Income Past Year -23,689,000
Net Income Prior Year -47,387,000
Quarterly Revenue Growth YOY 7.20%
5-Year Revenue Growth 8.01%

Balance Sheet

Total Cash Most Recent Quarter 36,493,000
Total Cash Past Year 36,493,000
Total Cash Prior Year 62,391,000
Net Cash Position Most Recent Quarter 16,998,000
Net Cash Position Past Year 16,998,000
Long Term Debt Past Year 19,495,000
Long Term Debt Prior Year 28,968,000
Total Debt Most Recent Quarter 19,495,000
Equity to Debt Ratio Past Year 0.54
Equity to Debt Ratio Most Recent Quarter 0.54
Total Stockholder Equity Past Year 22,694,000
Total Stockholder Equity Prior Year 42,460,000
Total Stockholder Equity Most Recent Quarter 22,694,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.11
MACD Signal -0.08
20-Day Bollinger Lower Band 1.42
20-Day Bollinger Middle Band 1.84
20-Day Bollinger Upper Band 2.26
Beta 1.23
RSI 31.67
50-Day SMA 2.28
200-Day SMA 8.07

System

Modified 3/27/2024 10:51:31 AM EST